Mislabeled medication recall (USA)

The FDA released the following statement this week regarding two types of medicines that may be mislabeled:

Qualitest and FDA is notifying pharmacists and patients of a recall to the retail level of specific lots of Butalbital, Acetaminophen, and Caffeine Tablets and Hydrocodone Bitartrate and Acetaminophen Tablets due to possibility that the recalled bottles may contain incorrect tablets, and patients may unintentionally take butalbital and caffeine instead of hydrocodone.

The recall involves the following products:

• Butalbital, Acetaminophen, and Caffeine Tablets, USP, 50mg/325mg/40mg, NDC 0603-2544-28 500 count, Lot Numbers C0390909A, C0400909A, C0410909A, C0590909B
• Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg / 500mg, NDC 0603-3882-32, 1000 count, Lot Numbers C0390909A, C0400909A, C0410909A, C0590909B

So this is what you need to do if you take either of the following.  First, double check your tablets and make sure you have the right ones.  Second, if you’ve already taken the wrong medication, report any side effects to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

Full information about the recall and reporting can be found at the FDA website here.